
Sign up to save your podcasts
Or


On this episode of Stock Movers:
- Nike (NKE) shares end the day higher after CEO Elliott Hill reported the purchase of about $1 million in shares. Last week, Apple CEO and Nike board member Tim Cook announced he was buying shares of the sportswear company.
- Trump Media and Technology Group (DJT) ends the day up more than 5% after the company said it plans to issue a new cryptocurrency, which will be distributed among its shareholders. Each of Trump Media’s shareholders will receive one token per share, the company said. Trump himself is the company’s largest shareholder with a 41% stake in the business, according to data compiled by Bloomberg.
- Corcept (CORT) shares plunged after US regulators rejected the company’s drug to treat a form of high blood pressure. The Food and Drug Administration “could not arrive at a favorable benefit-risk assessment” for the company’s drug, relacorilant, without more evidence of its effectiveness, the Redwood City, California-based company said in a statement Wednesday.
See omnystudio.com/listener for privacy information.
By iHeartPodcasts4.6
1919 ratings
On this episode of Stock Movers:
- Nike (NKE) shares end the day higher after CEO Elliott Hill reported the purchase of about $1 million in shares. Last week, Apple CEO and Nike board member Tim Cook announced he was buying shares of the sportswear company.
- Trump Media and Technology Group (DJT) ends the day up more than 5% after the company said it plans to issue a new cryptocurrency, which will be distributed among its shareholders. Each of Trump Media’s shareholders will receive one token per share, the company said. Trump himself is the company’s largest shareholder with a 41% stake in the business, according to data compiled by Bloomberg.
- Corcept (CORT) shares plunged after US regulators rejected the company’s drug to treat a form of high blood pressure. The Food and Drug Administration “could not arrive at a favorable benefit-risk assessment” for the company’s drug, relacorilant, without more evidence of its effectiveness, the Redwood City, California-based company said in a statement Wednesday.
See omnystudio.com/listener for privacy information.

403 Listeners

1,165 Listeners

2,168 Listeners

1,942 Listeners

415 Listeners

1,041 Listeners

1,302 Listeners

63 Listeners

65 Listeners

155 Listeners

81 Listeners

80 Listeners

72 Listeners

8 Listeners

2 Listeners